This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 94/3/353    most recent 01.RES.0000111801.48626.F4v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by El-Haroun, H. Articles by Knox, A. J. Search for Related Content PubMed PubMed Citation Articles by El-Haroun, H. Articles by Knox, A. J. Related Collections Pulmonary biology and circulation Smooth muscle proliferation and differentiation

(Circulation Research. 2004;94:353.)
© 2004 American Heart Association, Inc.

Cellular Biology

Interleukin-1ß, Transforming Growth Factor-ß₁, and Bradykinin Attenuate Cyclic AMP Production by Human Pulmonary Artery Smooth Muscle Cells in Response to Prostacyclin Analogues and Prostaglandin E₂ by Cyclooxygenase-2 Induction and Downregulation of Adenylyl Cyclase Isoforms 1, 2, and 4

H. El-Haroun, D. Bradbury, A. Clayton, Alan J. Knox

From the Division of Respiratory Medicine, University of Nottingham, City Hospital, Nottingham, UK.

Correspondence to Prof Alan J. Knox, Division of Respiratory Medicine, University of Nottingham, Clinical Science Building, City Hospital, Nottingham, NG5 1PB, England. E-mail alan.knox{at}nottingham.ac.uk

Increased levels of inflammatory cytokines contribute to the pathophysiology of pulmonary hypertension. Prostacyclin (PGI₂) analogues, which relax pulmonary vessels mainly through cAMP elevation, have a major therapeutic role. In this study, we show that prolonged incubation with bradykinin (BK), interleukin-1ß (IL-1ß), and transforming growth factor-ß₁ (TGF-ß₁) markedly impairs cAMP accumulation in human pulmonary artery smooth muscle cells in response to short-term incubation with prostaglandin E₂ (PGE₂) and the PGI₂ analogues iloprost and carbaprostacyclin. A similar reduction in cAMP accumulation in response to a direct adenylyl cyclase activator, forskolin, suggested that the effect was attributable to downregulation of adenylyl cyclase. Reverse transcriptase–polymerase chain reaction studies showed downregulation of adenylyl cyclase isoforms 1, 2, and 4. The effect of IL-1ß, BK, and TGF-ß₁ on cAMP levels was abrogated by the selective COX-2 inhibitor NS398. Furthermore, it was mimicked by prolonged incubation with the COX-2 product PGE₂ and PGI₂ analogues or the COX substrate arachidonic acid, suggesting that it was mediated by endogenous prostanoids produced by COX-2. Consistent with this, IL-1ß, BK, and TGF-ß₁ all induced COX-2 and PGE₂ release. These results show that BK, IL-1ß, and TGF-ß₁ downregulate adenylyl cyclase in human pulmonary artery smooth muscle cells via COX-2 induction and prostanoid release. This suggests a novel mechanism whereby mediators and cytokines produced in pulmonary hypertension may impair the therapeutic effects of prostacyclin analogues such as iloprost and carbaprostacyclin.

Key Words: interleukin-1ß • transforming growth factor-ß₁ • bradykinin • cAMP • adenylyl cyclase

This article has been cited by other articles:

				J. Roux, M. Carles, H. Koh, A. Goolaerts, M. T. Ganter, B. B. Chesebro, M. Howard, B. T. Houseman, W. Finkbeiner, K. M. Shokat, et al. Transforming Growth Factor {beta}1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphatidylinositol 3-Kinase-dependent Mechanism J. Biol. Chem., February 12, 2010; 285(7): 4278 - 4290. [Abstract] [Full Text] [PDF]

				N. Foudi, X. Norel, M. Rienzo, L. Louedec, C. Brink, J.-B. Michel, and M. Back Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1882 - H1888. [Abstract] [Full Text] [PDF]

				N. Foudi, L. Louedec, T. Cachina, C. Brink, and X. Norel Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation Cardiovasc Res, February 1, 2009; 81(2): 269 - 277. [Abstract] [Full Text] [PDF]

				L. De Franceschi, O. S. Platt, G. Malpeli, A. Janin, A. Scarpa, C. Leboeuf, Y. Beuzard, E. Payen, and C. Brugnara Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice FASEB J, June 1, 2008; 22(6): 1849 - 1860. [Abstract] [Full Text] [PDF]

				H. El-Haroun, D. L. Clarke, K. Deacon, D. Bradbury, A. Clayton, A. Sutcliffe, and A. J. Knox IL-1{beta}, BK, and TGF-{beta}1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L553 - L562. [Abstract] [Full Text] [PDF]

				T. Ito, T. Okada, H. Miyashita, T. Nomoto, M. Nonaka-Sarukawa, R. Uchibori, Y. Maeda, M. Urabe, H. Mizukami, A. Kume, et al. Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats Circ. Res., September 28, 2007; 101(7): 734 - 741. [Abstract] [Full Text] [PDF]

				F. Baratelli, Y. Lin, L. Zhu, S.-C. Yang, N. Heuze-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells J. Immunol., August 1, 2005; 175(3): 1483 - 1490. [Abstract] [Full Text] [PDF]

				A. Sobolewski, K. B. Jourdan, P. D. Upton, L. Long, and N. W. Morrell Mechanism of cicaprost-induced desensitization in rat pulmonary artery smooth muscle cells involves a PKA-mediated inhibition of adenylyl cyclase Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L352 - L359. [Abstract] [Full Text] [PDF]